KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Goodwill (2016 - 2025)

Neogenomics (NEO) has disclosed Goodwill for 9 consecutive years, with $522.8 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Goodwill changed 0.0% year-over-year to $522.8 million, compared with a TTM value of $522.8 million through Dec 2023, changed 0.0%, and an annual FY2023 reading of $522.8 million, changed 0.0% over the prior year.
  • Goodwill was $522.8 million for Q4 2023 at Neogenomics, roughly flat from $522.8 million in the prior quarter.
  • Across five years, Goodwill topped out at $527.1 million in Q4 2021 and bottomed at $196.3 million in Q1 2019.
  • Average Goodwill over 5 years is $364.5 million, with a median of $366.8 million recorded in 2020.
  • The sharpest move saw Goodwill rose 7.4% in 2020, then decreased 0.83% in 2022.
  • Year by year, Goodwill stood at $198.6 million in 2019, then grew by 6.14% to $210.8 million in 2020, then surged by 150.05% to $527.1 million in 2021, then decreased by 0.83% to $522.8 million in 2022, then changed by 0.0% to $522.8 million in 2023.
  • Business Quant data shows Goodwill for NEO at $522.8 million in Q4 2023, $522.8 million in Q4 2022, and $527.1 million in Q2 2022.